Can stroma reaction predict cancer lethality?
Where this comes from
- Record sourced from PubMed, PMID 24009149.
- Also identified by DOI 10.1158/1078-0432.CCR-13-1694 and PMC identifier 3983789.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stromal features in carcinomas may provide a relatively consistent means to stratify patients afflicted with solid tumors. Stroma-derived transcriptome signatures can now be used to make predictions about patient survival, suggesting the potential for their clinical application in precision medicine to predict disease progression and emergence of therapeutic resistance.
Medical subject headings
- Neoplasms
- Stromal Cells